Showing 1 - 17 results of 17 for search 'Ezra E.W. Cohen', query time: 0.05s
Refine Results
-
1
Current perspectives on recurrent HPV-mediated oropharyngeal cancer by Theresa Guo, Stephen Y. Kang, Ezra E. W. Cohen
Published 2022-08-01
Article -
2
-
3
Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities by Robert Saddawi-Konefka, Robert Saddawi-Konefka, Aaron B. Simon, Aaron B. Simon, Whitney Sumner, Whitney Sumner, Andrew Sharabi, Andrew Sharabi, Loren K. Mell, Loren K. Mell, Ezra E. W. Cohen, Ezra E. W. Cohen
Published 2021-09-01
Article -
4
Pan-Cancer Analysis of Patient Tumor Single-Cell Transcriptomes Identifies Promising Selective and Safe Chimeric Antigen Receptor Targets in Head and Neck Cancer by Sanna Madan, Sanju Sinha, Tiangen Chang, J. Silvio Gutkind, Ezra E. W. Cohen, Alejandro A. Schäffer, Eytan Ruppin
Published 2023-10-01
Article -
5
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors. by Wen-Liang Kuo, Marina N Sharifi, Mark W Lingen, Omar Ahmed, Jing Liu, Madhavi Nagilla, Kay F Macleod, Ezra E W Cohen
Published 2014-01-01
Article -
6
-
7
Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway by Sayuri Miyauchi, Sangwoo S. Kim, Riley N. Jones, Lin Zhang, Kripa Guram, Sonia Sharma, Stephen P. Schoenberger, Ezra E.W. Cohen, Joseph A. Califano, Andrew B. Sharabi
Published 2023-05-01
Article -
8
Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma receiving tumor-... by Gregory A Daniels, Brooke M Helfer, Eric T Ahrens, Karen Messer, Hongyan Xu, Charles F O’Hanlon, Deanne R Lister, Julie L Bykowski, Benjamin I Leach, Jiawen Chen, Ezra E W Cohen
Published 2023-06-01
Article -
9
Programmed death 1 (PD‐1) and ligand (PD‐L1) inhibitors in head and neck squamous cell carcinoma: A meta‐analysis by Dylan A. Levy, Jaimin J. Patel, Shaun A. Nguyen, W. Nicholas Jungbauer, David M. Neskey, Ezra E. W. Cohen, Chrystal M. Paulos, John A. Kaczmar, Hannah M. Knochelmann, Terry A. Day
Published 2022-09-01
Article -
10
Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4+ T cells by Spencer E. Brightman, Martin S. Naradikian, Rukman R. Thota, Angelica Becker, Leslie Montero, Milad Bahmanof, Ashmitaa Logandha Ramamoorthy Premlal, Jason A. Greenbaum, Bjoern Peters, Ezra E.W. Cohen, Aaron M. Miller, Stephen P. Schoenberger
Published 2023-01-01
Article -
11
Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression by Joseph S. Dolina, Joey Lee, Spencer E. Brightman, Sara McArdle, Samantha M. Hall, Rukman R. Thota, Karla S. Zavala, Manasa Lanka, Ashmitaa Logandha Ramamoorthy Premlal, Jason A. Greenbaum, Ezra E. W. Cohen, Bjoern Peters, Stephen P. Schoenberger
Published 2023-09-01
Article -
12
DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer. by Tanguy Y Seiwert, XiaoZhe Wang, Jana Heitmann, Vivian Villegas-Bergazzi, Kam Sprott, Stephen Finn, Esther O'Regan, Allan D Farrow, Ralph R Weichselbaum, Mark W Lingen, Ezra E W Cohen, Kerstin Stenson, David T Weaver, Everett E Vokes
Published 2014-01-01
Article -
13
Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer by Zhiyong Wang, Yusuke Goto, Michael M. Allevato, Victoria H. Wu, Robert Saddawi-Konefka, Mara Gilardi, Diego Alvarado, Bryan S. Yung, Aoife O’Farrell, Alfredo A. Molinolo, Umamaheswar Duvvuri, Jennifer R. Grandis, Joseph A. Califano, Ezra E. W. Cohen, J. Silvio Gutkind
Published 2021-04-01
Article -
14
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy by Dina V. Hingorani, Michael M. Allevato, Maria F. Camargo, Jacqueline Lesperance, Maryam A. Quraishi, Joseph Aguilera, Ida Franiak-Pietryga, Daniel J. Scanderbeg, Zhiyong Wang, Alfredo A. Molinolo, Diego Alvarado, Andrew B. Sharabi, Jack D. Bui, Ezra E. W. Cohen, Stephen R. Adams, J. Silvio Gutkind, Sunil J. Advani
Published 2022-07-01
Article -
15
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4 by Zhiyong Wang, Victoria H. Wu, Michael M. Allevato, Mara Gilardi, Yudou He, Juan Luis Callejas-Valera, Lynn Vitale-Cross, Daniel Martin, Panomwat Amornphimoltham, James Mcdermott, Bryan S. Yung, Yusuke Goto, Alfredo A. Molinolo, Andrew B. Sharabi, Ezra E. W. Cohen, Qianming Chen, J. Guy Lyons, Ludmil B. Alexandrov, J. Silvio Gutkind
Published 2019-12-01
Article -
16
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions by J. Silvio Gutkind, Alfredo A. Molinolo, Xingyu Wu, Zhiyong Wang, Daniela Nachmanson, Olivier Harismendy, Ludmil B. Alexandrov, Beverly R. Wuertz, Frank G. Ondrey, Denise Laronde, Leigha D. Rock, Miriam Rosin, Charles Coffey, Valerie D. Butler, Lisa Bengtson, Chiu-Hsieh Hsu, Julie E. Bauman, Stephen M. Hewitt, Ezra E.W. Cohen, H-H. Sherry Chow, Scott M. Lippman, Eva Szabo
Published 2021-09-01
Article -
17
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC by Robert Saddawi-Konefka, Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Shawn M. Jensen, Bryan S. Yung, Zhiyong Wang, Victoria H. Wu, Nana-Ama Anang, Riyam Al Msari, Shiruyeh Schokrpur, Ida Franiak Pietryga, Alfredo A. Molinolo, Jill P. Mesirov, Aaron B. Simon, Bernard A. Fox, Jack D. Bui, Andrew Sharabi, Ezra E. W. Cohen, Joseph A. Califano, J. Silvio Gutkind
Published 2022-07-01
Article